Hint mode is switched on Switch off

BIB - ProShares Ultra Nasdaq Biotechnology (USD) (US74347R2141)

The comparsion limit has been reached: only 5 tools has been added. To add a new one, please remove one of the existing tools.

Choose all Reset all

Leveraged

 
(%)
US74347R2141
BIB ISIN
Exchange Traded Funds (ETF)
Type of fund
ProShares
Provider
99.84 USD
NAV per Share | 21/07/2026
07/04/2010
Inception Date
4 times per year
Dividend payments
CEOJLS
CFI
BIB
Ticker
Formed
Status
Equity
Investment category
Biotech
Sector
USA
Investor locations
Nasdaq Biotechnology® Index
Benchmark
0.95 %
Total Cost Ratio
83.86 mln USD
Fund NAV | 21/07/2026
83.86 mln USD
Share Class NAV | 21/07/2026
No
UCITS

Upgrade to Premium features

Cbonds consolidates global bond, stock, ETF and indices data into a single platform — so you can analyze faster, make informed investment decisions and outperform the market

Get access
Welcome to Cbonds

  • Full access to the largest bond database

    Bond parameters,
    prospectuses

  • Seamless
    Data export

    Analyze the data in the most efficient way

  • Bond pricing

    Current & historical quotes from 400+ stock exchanges & OTC market

  • Smart risk assessment

    Credit ratings, financial reports

Get access

Yield on 21/07/2026, NASDAQ

  • YTD
    -2.97 %
  • 1M
    -13.62 %
  • 3M
    -11.24 %
  • 6M
    -0.65 %
  • 1Y
    81.38 %
  • 3Y
    46.02 %
  • 5Y
    -4.77 %
  • 10Y
    -
At the price on the exchange, taking into account income payments

Latest data on
Add to compare
from
to
ADD-IN
Cbonds add-in API
bond data api

Quotes (BIB)

Explore the most comprehensive database

1 000 000

bonds

100 000

stocks

175 910

ETF & Funds

100 000

indices

Track your portfolio in the most efficient way

  • Bond Search
  • Watchlist
  • Excel ADD-IN
Get access
×

— Are you looking for the complete & verified bond data?

— We have everything you need:

full data on over 1 000 000 bonds, 100 000 stocks, 100 000 indices, 17 000 ETF and 150 000 Mutual Funds; powerful bond screener; over 350 pricing sources among stock exchanges & OTC market; ratings & financial reports; user-friendly interface; available anywhere via Website, Excel Add-in and Mobile app.

Register
×

Why

You will have detailed descriptive & pricing data for 1M bonds, 100K stocks, 100K indices, 17K ETF and 150K Mutual Funds
Get full access to the platform from any device & via Cbonds app
Enhance your portfolio management with Cbonds Excel Add-in
Build yield maps, make chart comparison within a click
Don't wait any longer — start using Cbonds today! Register

Price dynamics

BIB profile

The ProShares Ultra Nasdaq Biotechnology (USD) is a(n) Equity Exchange Traded Funds (ETF) seeks to invest in Biotech sector located in USA. The ProShares fund’s base currency is USD and the share class was registered 07.04.2010 with unique ISIN - US74347R2141. Main exchange is NASDAQ and ticker symbol is BIB. The total expense ratio is 0.95%. The ProShares Ultra Nasdaq Biotechnology (USD) pays dividends 4 time(s) per year.

Structure BIB on 21/07/2026

Download structure in Excel
Paper Value
CG ONCOLOGY INC 0%
CRISPR THERAPEUTICS AG 0%
VERACYTE INC 0%
DEFINIUM THERAPEUTICS INC 0%
INDIVIOR PHARMACEUTICALS INC 0%
TRAVERE THERAPEUTICS INC 0%
10X GENOMICS INC-CLASS A 0%
ORUKA THERAPEUTICS INC 0%
AMNEAL PHARMACEUTICALS INC 0%
TWIST BIOSCIENCE CORP 0%
ERASCA INC 0%
SCHOLAR ROCK HOLDING CORP 0%
LIGAND PHARMACEUTICALS 0%
CARIS LIFE SCIENCES INC 0%
XENON PHARMACEUTICALS INC 0%
PTC THERAPEUTICS INC 0%
COGENT BIOSCIENCES INC 0%
MIRUM PHARMACEUTICALS INC 0%
RHYTHM PHARMACEUTICALS INC 0%
ABIVAX SA-ADR 0%
IMMUNOVANT INC 0%
APOGEE THERAPEUTICS INC 0%
VAXCYTE INC 0%
IMMUNITYBIO INC 0%
TEMPUS AI INC-CL A 0%
IDEAYA BIOSCIENCES INC 0%
UNIQURE NV 0%
TREVI THERAPEUTICS INC 0%
ATAIBECKLEY INC 0%
KODIAK SCIENCES INC 0%
VERA THERAPEUTICS INC 0%
SUPERNUS PHARMACEUTICALS INC 0%
BEAM THERAPEUTICS INC 0%
ULTRAGENYX PHARMACEUTICAL IN 0%
MBX BIOSCIENCES INC 0%
DISC MEDICINE INC 0%
KINIKSA PHARMACEUTICALS INTE 0%
GRAIL INC 0%
ALKERMES PLC 0%
ENLIVEN THERAPEUTICS INC 0%
ARCUTIS BIOTHERAPEUTICS INC 0%
ADAPTIVE BIOTECHNOLOGIES 0%
ALUMIS INC 0%
DENALI THERAPEUTICS INC 0%
STRUCTURE THERAPEUTICS INC 0%
DYNE THERAPEUTICS INC 0%
RELAY THERAPEUTICS INC 0%
TANGO THERAPEUTICS INC 0%
EDGEWISE THERAPEUTICS INC 0%
ACADIA PHARMACEUTICALS INC 0%
GILEAD SCIENCES INC 0%
UNITED THERAPEUTICS CORP 0%
INCYTE CORP 0%
INSMED INC 0%
MODERNA INC 0%
ARGENX SE - ADR 0%
ROIVANT SCIENCES LTD 0%
ROYALTY PHARMA PLC- CL A 0%
ILLUMINA INC 0%
BIOGEN INC 0%
ALNYLAM PHARMACEUTICALS INC 0%
REVOLUTION MEDICINES INC 0%
REGENERON PHARMACEUTICALS 0%
VIATRIS INC 0%
VERTEX PHARMACEUTICALS INC 0%
AMGEN INC 0%
THIRD HARMONIC BIO INC 0%
CARTESIAN THERAPEUTICS-CVR 0%
NEWAMSTERDAM PHARMA CO NV 0%
PROSHARES GENIUS MNY MKT ETF 0%
NASDAQ Biotechnology Index SWAP UBS AG 0%
NASDAQ Biotechnology Index SWAP Societe Generale 0%
NASDAQ Biotechnology Index SWAP Goldman Sachs International 0%
NASDAQ Biotechnology Index SWAP Bank of America NA 0%
NASDAQ Biotechnology Index SWAP Citibank NA 0%
CYTOKINETICS INC 0%
IONIS PHARMACEUTICALS INC 0%
CRINETICS PHARMACEUTICALS IN 0%
PRAXIS PRECISION MEDICINES I 0%
PROTAGONIST THERAPEUTICS INC 0%
SPYRE THERAPEUTICS INC 0%
HALOZYME THERAPEUTICS INC 0%
KYMERA THERAPEUTICS INC 0%
KRYSTAL BIOTECH INC 0%
SANOFI-ADR 0%
ARROWHEAD PHARMACEUTICALS IN 0%
BEONE MEDICINES LTD-ADR 0%
BIONTECH SE-ADR 0%
NASDAQ Bio Index SWAP BNP Paribas 0%
SUMMIT THERAPEUTICS INC 0%
BIOMARIN PHARMACEUTICAL INC 0%
AXSOME THERAPEUTICS INC 0%
MADRIGAL PHARMACEUTICALS INC 0%
EXELIXIS INC 0%
MEDPACE HOLDINGS INC 0%
ASCENDIS PHARMA A/S 0%
JAZZ PHARMACEUTICALS PLC 0%
BRIDGEBIO PHARMA INC 0%
NEUROCRINE BIOSCIENCES INC 0%
GUARDANT HEALTH INC 0%
Show more Hide
Other - %

Get access to the largest financial database

Try in 7-days Demo access

Free for company representative

  • Evaluate advanced analytical tools
  • Get full online access to the database
  • Try our powerful bond screener
  • Track bond prices from 400+ sources

Get access to the largest financial database

Representative of the company 7 days FREE trial

Professional access to the data

Private investor

Individual access

Other ETF & Funds from this provider

Similar ETF & Funds

  • {{ item.etf.ttl }}
    {{ item.nav_usd }} mln
    NAV
    {{ item.expense_ratio }}
    Total Cost Ratio
Registration is required to get access.